Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 2
2000 2
2001 1
2002 2
2003 1
2004 1
2005 2
2006 6
2008 2
2009 1
2010 2
2011 1
2012 2
2013 2
2014 11
2015 5
2016 5
2017 4
2018 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Results by year
Filters applied: . Clear all
Page 1
High Prevalence of Sarcopenia in HIV-Infected Individuals.
Echeverría P, Bonjoch A, Puig J, Estany C, Ornelas A, Clotet B, Negredo E. Echeverría P, et al. Among authors: Bonjoch A. Biomed Res Int. 2018 Jul 12;2018:5074923. doi: 10.1155/2018/5074923. eCollection 2018. Biomed Res Int. 2018. PMID: 30112397 Free PMC article.
Management of bone mineral density in HIV-infected patients.
Negredo E, Bonjoch A, Clotet B. Negredo E, et al. Among authors: Bonjoch A. Expert Opin Pharmacother. 2016;17(6):845-52. doi: 10.1517/14656566.2016.1146690. Epub 2016 Feb 15. Expert Opin Pharmacother. 2016. PMID: 26809940 Review.
Association between lipid genetic and immunological status in chronically HIV-infected patients.
Echeverría P, Guardiola M, González M, Vallvé JC, Puig J, Bonjoch A, Clotet B, Ribalta J, Negredo E. Echeverría P, et al. Among authors: Bonjoch A. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19555. doi: 10.7448/IAS.17.4.19555. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394062 Free PMC article.
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
Negredo E, Langohr K, Bonjoch A, Pérez-Alvárez N, Estany C, Puig J, Rosales J, Echeverría P, Clotet B, Gómez G. Negredo E, et al. Among authors: Bonjoch A. J Antimicrob Chemother. 2018 Sep 1;73(9):2452-2459. doi: 10.1093/jac/dky201. J Antimicrob Chemother. 2018. PMID: 29860519 Clinical Trial.
Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.
Negredo E, Estrada V, Domingo P, Gutiérrez MD, Mateo GM, Puig J, Bonjoch A, Ornelas A, Echeverría P, Estany C, Toro J, Clotet B. Negredo E, et al. Among authors: Bonjoch A. J Antimicrob Chemother. 2017 Mar 1;72(3):844-849. doi: 10.1093/jac/dkw504. J Antimicrob Chemother. 2017. PMID: 27999056 Clinical Trial.
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B; MULTINEKA Study Group. Negredo E, et al. Among authors: Bonjoch A. Clin Infect Dis. 2009 Sep 15;49(6):892-900. doi: 10.1086/605440. Clin Infect Dis. 2009. PMID: 19663689 Clinical Trial.
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.
Echeverría P, Guardiola M, González M, Vallvé JC, Puig J, Bonjoch A, Clotet B, Ribalta J, Negredo E. Echeverría P, et al. Among authors: Bonjoch A. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19557. doi: 10.7448/IAS.17.4.19557. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394064 Free PMC article.
Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals.
Juega-Mariño J, Bonjoch A, Pérez-Alvarez N, Negredo E, Bayes B, Bonet J, Clotet B, Romero R. Juega-Mariño J, et al. Among authors: Bonjoch A. Medicine (Baltimore). 2017 Sep;96(37):e7421. doi: 10.1097/MD.0000000000007421. Medicine (Baltimore). 2017. PMID: 28906351 Free PMC article. Clinical Trial.
54 results
Jump to page
Feedback